Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
Related Questions
When do you consider disease modifying therapy in radiographically isolated syndrome?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
What biomarkers best predict the response to B-cell depleting therapies in MS?
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
Which patients will have earlier diagnosis of multiple sclerosis via the new 2024 McDonald Criteria?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
How does your decision to use high-efficacy disease-modifying treatments (HET) differ, if at all, when treating late-onset relapsing-remitting multiple sclerosis?
